
Charles Bernstein
Articles
-
Jun 5, 2024 |
giendo.theclinics.com | Max Rady College |Charles Bernstein
Keywords Endoscopy assessment Interobserver agreement Disease activity Mucosal healing To read this article in full you will need to make a payment Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access One-time access price info For academic or personal research use, select 'Academic and Personal' For corporate R&D use, select 'Corporate R&D Professionals' Subscribers receive full online access to your subscription and archive of back issues up to and...
-
Jun 4, 2024 |
winnipegfreepress.com | Charles Bernstein
I am writing to shed light on the shameful display of ignorance and insensitivity by the graduation class valedictory speech at the Max Rady College of Medicine on May 16. At the University of Manitoba, considering the sizable First Nations population of Manitoba and long history of First Nations victimization, reconciliation with the Indigenous Canadian community is taken very seriously.
-
Nov 13, 2023 |
consultant360.com | Charles Bernstein
In this podcast, Charles Bernstein, MD, speaks about psychiatric comorbidities that occur in patients with Crohn disease and how they differ from other IBD disorders, the collaboration necessary within the clinician care team managing patients with IBD, and the connection between IBD symptoms and mental health.
-
May 31, 2023 |
bmjopen.bmj.com | Carol Hitchon |Christine M. Mesa |Charles Bernstein |Ruth Ann Marrie
ResultsBetween 12 March 2021 and 30 July 2022, we recruited 339 participants (online supplemental figure 2). Vaccination and disease activity data for the time points reported herein were available for 327 participants (78 IA: 77% rheumatoid arthritis; 84 SARDs: 57% lupus; 93 IBD: 43% Crohn’s; and 72 MS: 71% relapsing-remitting) (table 1). Most were female (79.4%) and white (84.7%), with a mean (SD) age of 56.0 (14.3) years.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →